SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Street Walker who started this subject4/2/2002 9:22:54 AM
From: MichaelSkyy   of 5582
 
Julie J. Johannsen to Lead Expansion of Flagship Zicam(R) Cold and Allergy
Brands

PHOENIX, April 2 /PRNewswire-FirstCall/ --
Gum Tech International Inc. (Nasdaq: GUMM), developer and distributor of
Zicam(R) Cold Remedy and Zicam(R) Allergy Relief, announced today the
appointment of Julie J. Johannsen as Director of Marketing.
Formerly senior brand manager in the personal cleansing division of The
Dial Corporation, Ms. Johannsen brings more than 15 years of national
marketing management of consumer packaged goods to Gum Tech. Before joining
Dial, she also successfully developed and executed marketing programs for
several high profile product lines for S.C. Johnson & Son, Inc., including
Curel(R), Aveeno(R), Shout(R) laundry products, Vanish(R) and Drano(R).
"The addition of Julie to the Gum Tech marketing team allows us to move
forward confidently with expansion of our successful Zicam product line," said
Carl J. Johnson, president and chief executive officer of Gum Tech. "Her
outstanding track record of award-winning product launches, brand extension
strategies and product positioning will provide a significant edge as we
strive to build market share in multiple product categories."
Ms. Johannsen, who achieved record sales and number one share ranking for
a number of high profile products during her career, said that she sees
tremendous potential in expanding the Zicam brand. "The rapid consumer
acceptance of these unique homeopathic cold and allergy products indicates a
real opportunity to grow market share for the product line," she noted. "I am
looking forward to applying my experience to both domestic and international
growth for the existing products and the exciting line extensions currently
under development."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext